Inhibition of PCSK9 enhances the anti-hepatocellular carcinoma effects of TCR-T cells and anti-PD-1 immunotherapy
International Journal of Biological Sciences · 2024 · 20 (10) · 3942-3955
DOI: 10.7150/ijbs.93668 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Weikang Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510220, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Proprotein Convertase 9, Immunotherapy. Die Arbeit wurde bisher 28-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510220, China.
- Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China; State Key Laboratory of Organ Failure Research; Key Laboratory of Infectious Diseases Research in South China, Ministry…
- Department of Pathology, The First People's Hospital of Foshan, Foshan 528000, China.
- Guangzhou Institute of Cardiovascular Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510220, China.
- Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510220, China.
Zitieren
APA
Xu, W., Hu, M., Lu, X., Lao, Y., Ma, N., Wang, Y., Li, J., Chen, X., Liu, S., Liu, J., Zhu, W., & Yang, H. (2024). Inhibition of PCSK9 enhances the anti-hepatocellular carcinoma effects of TCR-T cells and anti-PD-1 immunotherapy. International Journal of Biological Sciences, 20(10), 3942-3955. https://doi.org/10.7150/ijbs.93668
Vancouver
Xu W, Hu M, Lu X, Lao Y, Ma N, Wang Y, et al. Inhibition of PCSK9 enhances the anti-hepatocellular carcinoma effects of TCR-T cells and anti-PD-1 immunotherapy. International Journal of Biological Sciences. 2024;20(10):3942-3955. doi:10.7150/ijbs.93668
BibTeX
@article{Xu2024,
author = {Xu, Weikang and Hu, Minli and Lu, Xinyu and Lao, Yueqiong and Ma, Na and Wang, Yiyue and Li, Jing and Chen, Xingyuan and Liu, Shiming and Liu, Jing and Zhu, Wei and Yang, Hui},
title = {Inhibition of PCSK9 enhances the anti-hepatocellular carcinoma effects of TCR-T cells and anti-PD-1 immunotherapy},
journal = {International Journal of Biological Sciences},
year = {2024},
volume = {20},
number = {10},
pages = {3942--3955},
doi = {10.7150/ijbs.93668}
}
EUVIMED